Sort
27,075 grants matching “cholesterol”
VITAMIN D AND IMMUNOMODULATION IN CORONARY ARTERY DISEASE
$624,257Devendra K. Agrawal · Creighton University · R01 · FY2012 · HL
Primary Care Treatment for Overweight Adolescent Females
$624,085Victor J Stevens · Kaiser Foundation Research Institute · R01 · FY2007 · HD
Heart Matters: Collaborate and Leverage Evidence in an African American Rural Network to Implement Risk Reduction Strategies for CVD (Heart Matters: Co-Learn to Reduce CVD)
$623,776Gaurav J Dave · Univ Of North Carolina Chapel Hill · R01 · FY2025 · HL
Project Title: PROSPECT: Puerto Rico Observational Study of Psychosocial, Environmental, and Chronic Disease Trends
$623,725Josiemer Mattei · Harvard School Of Public Health · R01 · FY2021 · HL
PRIMECare Trial: Preventing Ischemic Heart Disease with mHealth, electronic decision support, and Community Health Workers.
$623,673Thomas A Gaziano · Harvard School Of Public Health · R01 · FY2023 · HL
Cellular Cholesterol Metabolism
$623,626Joseph L Goldstein · Ut Southwestern Medical Center · P01 · FY2015 · HL
Natural History of Microalbuminuria in Type 1 Diabetes
$623,525Andrzej S Krolewski · Joslin Diabetes Center · R01 · FY2008 · DK
ABCG1 Function in Diabetes
$623,425Catherine C Hedrick · La Jolla Institute For Immunology · R01 · FY2010 · HL
Restriction of Toxoplasma growth in human cells
$623,349Jeroen Saeij · University Of California At Davis · R01 · FY2024 · AI
An Integrative Science Approach to Resilience: The Notre Dame Study of Health & Well-being
$623,278Cindy S Bergeman · University Of Notre Dame · UH3 · FY2021 · AG
ACCORD
$623,172J Thomas Bigger · Columbia University Health Sciences · N01 · FY2010 · HL
A Neurobehavioral Family Study of Schizophrenia
$623,171University Of Pittsburgh At Pittsburgh · R01 · FY2004 · MH
The effects of PD-1 on tumor-mediated âemergencyâ myelopoiesis and fate commitment of myeloid cells: Implications for anti-tumor immunity
$623,127Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R01 · FY2024 · CA
Clinical Investigations of Niemann-Pick Disease, type C
$623,090Forbes Porter · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2014 · HD
Molecular and cellular mechanisms of neuronal damage caused by anticancer therapies
$623,067Joseph G Duman · Baylor College Of Medicine · R01 · FY2025 · CA
Aldosterone Synthase & Hypertension
$622,916Ashok Kumar Kumar · University Of Toledo Health Sci Campus · R01 · FY2015 · HL
Promoting Preconception Care and Diabetes Self-Management among Reproductive-Aged Women with Diabetes: The PREPARED Trial
$622,891Stacy C Bailey · Northwestern University At Chicago · R01 · FY2025 · DK
AIBP-mediated neuroprotection in glaucomatous optic neuropathy
$622,812Wonkyu Ju · University Of California, San Diego · R01 · FY2025 · EY
A Personalized Metabolomic Approach to Human Obesity and Weight Loss
$622,766Svati H. Shah · Duke University · R01 · FY2016 · HL
Weight management for adults with mobility related disabilities
$622,526Joseph E. Donnelly · University Of Kansas Medical Center · R01 · FY2022 · DK
PRIMECare Trial: Preventing Ischemic Heart Disease with mHealth, electronic decision support, and Community Health Workers.
$622,149Thomas A Gaziano · Harvard School Of Public Health · R01 · FY2022 · HL
Diabetes and Heart Disease Risk in Blacks
$622,068Anne Sumner · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2011 · DK
Evaluating PQQ for preventing maternal obesity-induced fetal programming of juvenile NAFLD in Papio anubis
$622,049Karen R Jonscher · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2025 · DK
Metabolic regulation and inhibition of ATP-citrate lyase
$622,037Ronen Marmorstein · University Of Pennsylvania · R01 · FY2023 · CA
Characterizing pleiotropy in cardiometabolic phenotypes among diverse populations
$622,036Christy Leigh Avery · Univ Of North Carolina Chapel Hill · R01 · FY2021 · HL